cofepris glp-1 news Employer FAQs on the Rise of Drugs for Weight Loss and the Workplace Impact | Fisher Phillips Digital health company Ro launches

Description

When people stop taking the new generation of weight-loss drugs, they pile back on the kilos four times faster than they would after ending diet and exercise regimes, new research found Thursday.

These cutting-edge treatments offer a safe and effective solution to help you lose weight and improve your overall health

Zachariah Reitano, co-founder and CEO of Ro, the direct-to-patient healthcare company, discusses the ripple effects of GLP1 medications such as Ozempic and Wegovy.

Combining GLP-1 medications like semaglutide with antidepressants such as bupropion requires medical oversight

GLP-1 weight-loss drugs pose hidden risks for young women Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers